| COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ... The Lancet 397 (10286), 1725-1735, 2021 | 759 | 2021 |
| SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... The Lancet 397 (10283), 1459-1469, 2021 | 671 | 2021 |
| Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ... The Lancet Infectious Diseases 20 (12), 1390-1400, 2020 | 316 | 2020 |
| Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure CJ Reynolds, C Pade, JM Gibbons, AD Otter, KM Lin, D Muñoz Sandoval, ... Science 377 (6603), eabq1841, 2022 | 284 | 2022 |
| COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing T Peto, D Affron, B Afrough, A Agasu, M Ainsworth, A Allanson, K Allen, ... EClinicalMedicine 36, 2021 | 184 | 2021 |
| Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: from utility to prediction A Lamikanra, D Nguyen, P Simmonds, S Williams, EM Bentley, C Rowe, ... Transfusion 61 (10), 2837-2843, 2021 | 38 | 2021 |
| Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021 HJ Whitaker, S Elgohari, C Rowe, AD Otter, T Brooks, E Linley, I Hayden, ... Journal of Infection 83 (2), 237-279, 2021 | 26 | 2021 |
| mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P. 1 Brazilian variant H Parry, G Tut, R Bruton, S Faustini, C Stephens, P Saunders, C Bentley, ... Elife 10, e69375, 2021 | 24 | 2021 |
| BNT162b2 vaccination in people over 80 years of age induces strong humoral immune responses with cross neutralisation of P. 1 Brazilian variant HM Parry, G Tut, S Faustini, C Stephens, P Saunders, C Bentley, ... | 22 | 2021 |
| Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara–Bavaria Nordic vaccine against mpox in children: a national … SN Ladhani, AC Dowell, S Jones, B Hicks, C Rowe, J Begum, ... The Lancet Infectious Diseases 23 (9), 1042-1050, 2023 | 10 | 2023 |
| Following the Omicron wave, the majority of children in England have evidence of previous COVID infection C Oeser, H Whitaker, R Borrow, E Linley, S Tonge, C Rowe, A Otter, ... Journal of Infection 86 (3), 256-308, 2023 | 10 | 2023 |
| Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis CA Martin, J Nazareth, A Jarkhi, D Pan, M Das, N Logan, S Scott, L Bryant, ... EClinicalMedicine 58, 2023 | 9 | 2023 |
| Determinants of SARS-CoV-2 anti-spike antibody levels following BNT162b2 vaccination: cross-sectional analysis of 6,000 SIREN study participants AD Otter, S D’Arcangelo, H Whitaker, J Hewson, S Foulkes, A Atti, M Cole, ... medRxiv, 2022.04. 21.22274025, 2022 | 9 | 2022 |
| Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals AD Otter, S Jones, B Hicks, D Bailey, H Callaby, C Houlihan, T Rampling, ... Nature Communications 14 (1), 5948, 2023 | 6 | 2023 |
| Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response I Doykov, T Baldwin, J Spiewak, KC Gilmour, JM Gibbons, C Pade, ... Cell Reports Methods 2 (9), 2022 | 6 | 2022 |
| Analogous humoral antigen recognition between monkeypox-infected and smallpox-vaccinated individuals AD Otter, S Jones, B Hicks, D Bailey, H Callaby, C Houlihan, T Rampling, ... MedRxiv, 2022.12. 22.22283648, 2022 | 5 | 2022 |
| COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study HJ Whitaker, RSM Tsang, R Byford, C Aspden, E Button, PS Pillai, ... Journal of Infection 87 (4), 315-327, 2023 | 4 | 2023 |
| The quality control of animal cell lines and the prevention, detection and cure of contamination P Thraves, C Rowe Animal Cell Culture: Essential Methods, 255-296, 2011 | 4 | 2011 |
| Implementation and extended evaluation of the Euroimmun anti-SARS-CoV-2 IgG assay and its contribution to the United Kingdom’s COVID-19 public health response AD Otter, A Bown, S D’Arcangelo, D Bailey, A Semper, J Hewson, ... Microbiology Spectrum 10 (1), e02289-21, 2022 | 3 | 2022 |
| Speaking the Same Language: Use of the 1 st WHO International SARS-CoV-2 Immunoglobulin Standard to Achieve Comparability Between Commercial SARS … A Semper, P Rigsby, A Otter, G Mattiuzzo, N Almond, C Rowe, P Brangel, ... HARMONY Study, Speaking the Same Language: Use of the 1 st WHO International …, 2022 | 1 | 2022 |
